Anavex Life Sciences: "I'm intrigued because the Biogen data doesn't look that good. I think you stick with it. It's real spec, though, but I think you stick with it."
GS Acquisition Holdings: "That's a very important SPAC that I don't know enough about ... I've got to do more work on that particular SPAC because I do hear good things."
Nio: "We're done with Chinese IPOs. I want you to sell Nio ... I want you to sell half of it tomorrow, and I hope it goes up. I love your interest, but I am very worried about China."
Churchill Capital V: "I've got to do more work."
Upstart: "I don't understand the short position in Upstart. Why don't the meme people, the Apesters, whatever the heck they are [and] call themselves, go after that company because it is really good. Artificial intelligence lending. Would you please go after something good?"
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram
Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com